Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.20.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.20.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
FL.20.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
HK.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.8.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.8.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.8.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
HK.8.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.19.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.19.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.19.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.19.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GE.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GE.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GE.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GE.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.6.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.6.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
EG.6.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FU.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FU.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FU.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FU.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DV.7.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DV.7.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.7.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.7.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.86.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-802.098France
BA.2.86.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.86.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BA.2.86.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.3.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.3.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GN.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GN.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GN.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JG.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JG.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JG.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JG.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JD.1.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JD.1.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.1.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used